Com2uS, which has an operating loss of 16.7 billion won, made profits from stock investment and dramas

Reporter Paul Lee / approved : 2023-02-21 06:27:52
  • -
  • +
  • 인쇄
This article is translated by AI company Flitto and Alhpa Biz neural machine translation technology

[Alpha Biz=(Chicago) Reporter Paul Lee] Com2uS, whose operating profit has turned into a deficit due to the global economic recession, is drawing attention as it has gained profits and popularity through side jobs such as stock investment and dramas.

Com2uS' operating loss last year was 16.7 billion won.

Com2uS spent 67 billion won in October last year to buy 990,000 shares (4.2%) of SM Entertainment for about 67,700 won. As of 1:30 p.m. on February 20, it is recording a profit of about 55.8 billion won.

WYSIWYG Studios Co, whose major shareholder is Com2uS (38.13%), is the largest shareholder (20.13%) of RaemongRaein, the co-producer of the JTBC drama 'Reborn Rich'. The drama, which aired from November 18 to December 25 last year, was popular with the highest viewer rating of 26.9% based on Nielsen Korea. The investment industry expects RaemongRaein to generate stable sales with secondary additional profits such as copyright returns and other intellectual property rights (IP).

It is also noteworthy that Com2uS Holdings, the parent company of Com2uS, has been re-listed on Coinone, a virtual asset exchange with the second-largest shareholder (38.5%). Coinone's transaction fee, which resumed trading on the 16th, is 0.2% and withdrawal fee is 0.05 Wemix, ranking sixth in transaction amount as of this day.

 

Alphabiz Reporter Paul Lee(hoondork1977@alphabiz.co.kr)

주요기사

[Exclusive] Samsung Electronics Passes NVIDIA’s HBM3E 12-High Qualification Test, Secures Supply Deal2025.09.19
Civic Groups File Complaint Against Baemin and Coupang Eats Over Alleged Misleading “One-Person Free Delivery” Promotions2025.09.19
KT Confirms Additional Victims in Unauthorized Micro-Payment Case, Faces Criticism Over Initial Response2025.09.19
KFTC Grants Conditional Approval for Joint Venture Between Shinsegae Group and Alibaba Group2025.09.19
Supreme Court Rules in Favor of NTS on U.S. Unregistered Patent Royalties2025.09.19
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사